University of Cologne | MedPath Search

Clinical Trials

Find the latest clinical trials by condition, location & phase

Browse and search for drug monographs and related information

Approved pharmaceutical products by global regulatory authorities

Explore a comprehensive list of organizations, including their profiles and details

Latest updates on clinical trials, pharmaceuticals, and healthcare companies

|

Filters

Study Phase

Early Phase 1

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

Phase 4

Not Applicable

Recruitment Status

Recruiting

Not yet recruiting

Active, not recruiting

Completed

Suspended

Terminated

Withdrawn

Study Type

Interventional

Observational

Expanded Access

Others

Eligibility Sex

All

Female

Male

Healthy Volunteers

All

Include

Exclude

Found 407 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "University of Cologne"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

Efficacy of a Resources Activation Treatment on Tic-symptoms

Not Applicable

Conditions: Tic-Disorder

Interventions: Behavioral: Resources activation

First Posted Date: 2014-07-15

Last Posted Date: 2017-03-15

Lead Sponsor: University of Cologne

Target Recruit Count: 50

Registration Number: NCT02190370

Locations: 🇩🇪
University Hospital of Cologne, Department of Childhood and Adolescent Psychiatry and Psychotherapy, Cologne, Germany

Efficacy of a Habit Reversal Treatment on Tic-symptoms

Not Applicable

Conditions: Tic-Disorder

Interventions: Behavioral: Habit Reversal Training

First Posted Date: 2014-07-15

Last Posted Date: 2017-03-15

Lead Sponsor: University of Cologne

Target Recruit Count: 50

Registration Number: NCT02190383

Locations: 🇩🇪
University Hospital of Cologne, Department of Childhood and Adolescent Psychiatry and Psychotherapy, Cologne, Germany

EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer
Adenocarcinoma
NSCLC

Interventions: Drug: Crizotinib

First Posted Date: 2014-07-08

Last Posted Date: 2022-06-16

Lead Sponsor: University of Cologne

Target Recruit Count: 34

Registration Number: NCT02183870

Locations: 🇩🇪
LungenClinic Großhansdorf, Großhansdorf, Schleswig-Holstein, Germany
🇨🇭
Universitätsspital Basel, Basel, Switzerland
🇪🇸
CEIC Hospital General Universitario de Alicante, Alicante, Spain

and more 15 locations

JAK-inhibition in Recurrent Classical Hodgkin Lymphoma

Phase 2

Completed

Conditions: Recurrent Classical Hodgkin Lymphoma

Interventions: Drug: Ruxolitinib

First Posted Date: 2014-06-16

Last Posted Date: 2020-04-06

Lead Sponsor: University of Cologne

Target Recruit Count: 12

Registration Number: NCT02164500

Locations: 🇩🇪
1st Dept. of Medicine, Cologne University Hospital, Cologne, Germany

German Centre for Infection Research HIV Translational Platform

Recruiting

Conditions: HIV

First Posted Date: 2014-05-29

Last Posted Date: 2017-10-27

Lead Sponsor: University Hospital of Cologne

Target Recruit Count: 10000

Registration Number: NCT02149004

Locations: 🇩🇪
University Hospital of Cologne, Cologne, North Rhine-Westphalia, Germany

Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL

Phase 2

Terminated

Conditions: Myelodysplastic Syndrome (MDS)
Chronic Myelomonocytic Leukemia (CMML)

Interventions: Drug: birinapant
Drug: Azacitidine
Drug: Placebo

First Posted Date: 2014-05-28

Last Posted Date: 2016-10-20

Lead Sponsor: TetraLogic Pharmaceuticals

Target Recruit Count: 118

Registration Number: NCT02147873

Locations: 🇺🇸
University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland, United States
🇺🇸
Desert Hematology Oncology Medical Group, Rancho Mirage, California, United States
🇺🇸
Gabrail Cancer Center Research, Canton, Ohio, United States

and more 72 locations

Efficacy of Psychotherapy Treatment of Children With Tics

Not Applicable

Conditions: Tic-Disorder

Interventions: Behavioral: Resources activation
Behavioral: Habit Reversal Training

First Posted Date: 2014-05-22

Last Posted Date: 2017-03-16

Lead Sponsor: University of Cologne

Target Recruit Count: 100

Registration Number: NCT02144870

Locations: 🇩🇪
University Hospital of Cologne, Department of Childhood and Adolescent Psychiatry and Psychotherapy, Cologne, Germany

Treatment of Children With Peer Related Aggressive Behavior (ScouT)

Not Applicable

Conditions: Oppositional Defiant Disorder

Interventions: Behavioral: Treatment Program with techniques to activate resources
Behavioral: Social Skills Training

First Posted Date: 2014-05-21

Last Posted Date: 2017-03-16

Lead Sponsor: University of Cologne

Target Recruit Count: 140

Registration Number: NCT02143427

Locations: 🇩🇪
Department of Child and Adolescent Psychiatry at the University Cologne, Cologne, Germany

Selinexor in Initial or Refractory and/or Relapsed Richter's Transformation

Phase 2

Terminated

Conditions: Richter's Transformation

Interventions: Drug: selinexor

First Posted Date: 2014-05-15

Last Posted Date: 2023-01-26

Lead Sponsor: Karyopharm Therapeutics Inc

Target Recruit Count: 27

Registration Number: NCT02138786

Locations: 🇺🇸
University of Arizona Cancer Center, Tucson, Arizona, United States
🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
🇩🇪
University of Ulm, Ulm, Baden-Württemberg, Germany

and more 14 locations

Prevention and Intervention of Externalizing Problem Behavior in School: Development and Evaluation of a Teacher Coaching.

Not Applicable

Conditions: Problematic Behavior in Children

Interventions: Behavioral: Teacher Coaching

First Posted Date: 2014-04-16

Last Posted Date: 2017-03-15

Lead Sponsor: University of Cologne

Target Recruit Count: 53

Registration Number: NCT02116088

Locations: 🇩🇪
University Clinic of Cologne, Cologne, North Rhine-Westphalia, Germany

Prev
1
20
21
22
23
24
41
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy